- Home
- JHI vs THTX Comparison
JHI vs THTX Comparison
Compare JHI & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHI
- THTX
- Stock Information
- Founded
- JHI 1971
- THTX 1993
- Country
- JHI United States
- THTX Canada
- Employees
- JHI N/A
- THTX N/A
- Industry
- JHI Trusts Except Educational Religious and Charitable
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- JHI Finance
- THTX Health Care
- Exchange
- JHI Nasdaq
- THTX Nasdaq
- Market Cap
- JHI 125.7M
- THTX 144.8M
- IPO Year
- JHI N/A
- THTX N/A
- Fundamental
- Price
- JHI $14.17
- THTX $3.30
- Analyst Decision
- JHI
- THTX Hold
- Analyst Count
- JHI 0
- THTX 1
- Target Price
- JHI N/A
- THTX N/A
- AVG Volume (30 Days)
- JHI 29.5K
- THTX 345.2K
- Earning Date
- JHI 01-01-0001
- THTX 10-09-2025
- Dividend Yield
- JHI 6.80%
- THTX N/A
- EPS Growth
- JHI N/A
- THTX N/A
- EPS
- JHI 1.05
- THTX N/A
- Revenue
- JHI N/A
- THTX $84,378,000.00
- Revenue This Year
- JHI N/A
- THTX N/A
- Revenue Next Year
- JHI N/A
- THTX $13.76
- P/E Ratio
- JHI $12.47
- THTX N/A
- Revenue Growth
- JHI N/A
- THTX 2.19
- 52 Week Low
- JHI $11.63
- THTX $1.12
- 52 Week High
- JHI $13.40
- THTX $3.31
- Technical
- Relative Strength Index (RSI)
- JHI 50.45
- THTX 75.09
- Support Level
- JHI $14.13
- THTX $3.18
- Resistance Level
- JHI $14.51
- THTX $3.27
- Average True Range (ATR)
- JHI 0.09
- THTX 0.02
- MACD
- JHI 0.01
- THTX -0.00
- Stochastic Oscillator
- JHI 20.93
- THTX 85.71
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.